Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma.
about
Molecular diagnostic approach to non-Hodgkin's lymphoma.Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.Novel real-time PCR assay using a universal molecular marker for diagnosis of hematologic cancers.Detection of B- and T-cell-specific gene rearrangements in 13 cell lines and 50 clinical specimens using the BIOMED-2 and the original InVivoScribe primers.Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions.
P2860
Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Development and validation of ...... kemia and follicular lymphoma.
@ast
Development and validation of ...... kemia and follicular lymphoma.
@en
type
label
Development and validation of ...... kemia and follicular lymphoma.
@ast
Development and validation of ...... kemia and follicular lymphoma.
@en
prefLabel
Development and validation of ...... kemia and follicular lymphoma.
@ast
Development and validation of ...... kemia and follicular lymphoma.
@en
P2093
P2860
P1476
Development and validation of ...... kemia and follicular lymphoma.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65355-2
P407
P577
1999-04-01T00:00:00Z